An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotides.
Stepkowski
S M
SM
Division of Immunology and Organ Transplantation, University of Texas-Houston, Houston, Texas, USA.
Chen
W
W
Geary
R
R
Wang
M E
ME
Condon
T
T
Stecker
K
K
Bennett
C F
CF
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology; D005786:Gene Expression Regulation / Q000187:drug effects / Q000276:immunology; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics*; D016030:Kidney Transplantation / Q000276:immunology*; D020319:Oligodeoxyribonucleotides, Antisense / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous / Q000276:immunology
D020319:Oligodeoxyribonucleotides, Antisense; D012333:RNA, Messenger; D018799:Intercellular Adhesion Molecule-1